Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
27.27
-0.61 (-2.19%)
At close: May 17, 2024, 4:00 PM
27.56
+0.29 (1.06%)
After-hours: May 17, 2024, 7:15 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $12.31 billion as of May 17, 2024. Its market cap has decreased by -41.23% in one year.
Market Cap
12.31B
Enterprise Value
16.92B
1-Year Change
-41.23%
Ranking
Category
Stock Price
$27.27
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from $26.49B to $12.31B, a decrease of -53.54%. That is a compound annual growth rate of -17.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 16.29B | -2.19% |
May 16, 2024 | 16.66B | -1.17% |
May 15, 2024 | 16.85B | 0.50% |
May 14, 2024 | 16.77B | -1.09% |
May 13, 2024 | 16.96B | 1.03% |
May 10, 2024 | 16.78B | 0.43% |
May 9, 2024 | 16.71B | -0.07% |
May 8, 2024 | 16.72B | -1.03% |
May 7, 2024 | 16.90B | -0.74% |
May 6, 2024 | 17.02B | 0.28% |
May 3, 2024 | 16.97B | -1.22% |
May 2, 2024 | 17.18B | 2.46% |
May 1, 2024 | 16.77B | 1.34% |
Apr 30, 2024 | 16.55B | -1.49% |
Apr 29, 2024 | 16.80B | 0.43% |
Apr 26, 2024 | 16.73B | -0.39% |
Apr 25, 2024 | 16.79B | 0.46% |
Apr 24, 2024 | 16.72B | 0.58% |
Apr 23, 2024 | 16.62B | - |
Apr 22, 2024 | 16.62B | -1.21% |
Apr 19, 2024 | 16.82B | 0.97% |
Apr 18, 2024 | 16.66B | 1.01% |
Apr 17, 2024 | 16.50B | 0.55% |
Apr 16, 2024 | 16.41B | -2.80% |
Apr 15, 2024 | 16.88B | 0.11% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fresenius Medical Care AG & Co. KGaA | 12.86B |
Incyte | 12.84B |
Tenet Healthcare | 12.56B |
Sarepta Therapeutics | 12.42B |
ShockWave Medical | 12.39B |
DaVita | 12.26B |
Medpace Holdings | 12.19B |
United Therapeutics | 12.15B |